Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Revolution Medicines, Inc.(RVMD) | 604,514 | 580,678 | -23,836 | $48.15M | $56.47M | 12.85% | +$8.32M |
| Spdr S&p Biotech EtfETF ST STR SP BIOT | 336,505 | 318,505 | -18,000 | $41.03M | $40.68M | 9.25% | -$347.4K |
| Stereotaxis, Inc.(STXS) | 13,680,554 | 13,680,554 | 0 | $31.47M | $25.17M | 5.73% | -$6.29M |
| Day One Biopharmaceuticals I COM | 999,163 | 978,463 | -20,700 | $9.31M | $20.98M | 4.77% | +$11.67M |
| AtriCure, Inc.(ATRC) | 597,431 | 597,431 | 0 | $23.63M | $17.04M | 3.88% | -$6.59M |
| IDEAYA Biosciences, Inc.(IDYA) | 506,740 | 476,740 | -30,000 | $17.52M | $15.88M | 3.61% | -$1.63M |
| Xenon Pharmaceuticals Inc.(XENE) | 287,939 | 250,772 | -37,167 | $12.91M | $14.58M | 3.32% | +$1.68M |
| Cytokinetics, Incorporated(CYTK) | 370,997 | 217,497 | -153,500 | $23.57M | $14.34M | 3.26% | -$9.24M |
| COMPASS Pathways plcADS(CMPS) | 811,046 | 2,418,882 | +1,607,836 | $5.60M | $13.38M | 3.04% | +$7.78M |
| Nektar Therapeutics(NKTR) | 74,998 | 165,178 | +90,180 | $3.17M | $11.88M | 2.70% | +$8.71M |
| Ishares Nasdaq Biotech IndxETF | 68,095 | 62,095 | -6,000 | $11.49M | $10.48M | 2.39% | -$1.01M |
| Arcus Biosciences, Inc.(RCUS) | 431,329 | 443,829 | +12,500 | $10.28M | $9.59M | 2.18% | -$691.9K |
| Neurocrine Biosciences, Inc.(NBIX) | 70,615 | 70,615 | 0 | $10.02M | $9.30M | 2.12% | -$712.5K |
| Larimar Therapeutics, Inc.(LRMR) | 939,164 | 2,029,164 | +1,090,000 | $3.58M | $9.13M | 2.08% | +$5.55M |
| Bicara Therapeutics Inc | 261,583 | 421,733 | +160,150 | $4.40M | $8.39M | 1.91% | +$3.99M |
| Axogen, Inc.(AXGN) | 476,826 | 249,960 | -226,866 | $15.61M | $8.28M | 1.88% | -$7.33M |
| Biohaven Ltd.(BHVN) | 955,235 | 845,735 | -109,500 | $10.78M | $7.15M | 1.63% | -$3.63M |
| Tandem Diabetes Care, Inc.(TNDM) | 355,208 | 355,208 | 0 | $7.81M | $6.81M | 1.55% | -$998.1K |
| Denali Therapeutics Inc.(DNLI) | 318,500 | 318,500 | 0 | $5.26M | $6.12M | 1.39% | +$856.8K |
| Ascendis Pharma A/SNOTE 2 250 4 0(ASND) | 0 | 0 | 0 | $5.46M | $5.92M | 1.35% | +$456.5K |
| Century Therapeutics, Inc.(IPSC) | 2,793,586 | 2,434,353 | -359,233 | $2.78M | $5.50M | 1.25% | +$2.72M |
| DexCom, Inc.(DXCM) | 88,279 | 86,279 | -2,000 | $5.86M | $5.42M | 1.23% | -$440.8K |
| Kalvista Pharmaceuticals Inc | 356,802 | 267,402 | -89,400 | $5.76M | $5.38M | 1.22% | -$379.6K |
| Ascendis Pharma A/SADR(ASND) | 28,177 | 23,177 | -5,000 | $6.01M | $5.30M | 1.21% | -$707.2K |
| MBX Biosciences, Inc.(MBX) | 165,265 | 175,465 | +10,200 | $5.21M | $5.24M | 1.19% | +$25.2K |
| Inogen, Inc.(INGN) | 827,071 | 845,179 | +18,108 | $5.56M | $5.22M | 1.19% | -$334.7K |
| Syndax Pharmaceuticals, Inc.(SNDX) | 277,855 | 217,355 | -60,500 | $5.84M | $5.08M | 1.16% | -$760.3K |
| Alkermes plcSHS(ALKS) | 130,248 | 139,482 | +9,234 | $3.64M | $4.93M | 1.12% | +$1.29M |
| Stoke Therapeutics, Inc.(STOK) | 108,875 | 130,875 | +22,000 | $3.46M | $4.26M | 0.97% | +$805.6K |
| BioCryst Pharmaceuticals, Inc.(BCRX) | 418,255 | 430,248 | +11,993 | $3.26M | $4.10M | 0.93% | +$833.6K |
| Lakefront Biotherapeutics NVADR(LKFT) | 130,175 | 130,175 | 0 | $4.26M | $3.91M | 0.89% | -$351.5K |
| Immunovant, Inc.(IMVT) | 150,524 | 150,524 | 0 | $3.83M | $3.74M | 0.85% | -$87.3K |
| Edgewise Therapeutics, Inc.(EWTX) | 159,736 | 112,236 | -47,500 | $3.96M | $3.54M | 0.80% | -$428.4K |
| MapLight Therapeutics, Inc.(MPLT) | 143,764 | 171,006 | +27,242 | $2.53M | $3.48M | 0.79% | +$951.3K |
| Allogene Therapeutics Inc | 1,380,118 | 1,370,118 | -10,000 | $1.89M | $3.34M | 0.76% | +$1.45M |
| PROCEPT BioRobotics Corporation(PRCT) | 120,000 | 120,000 | 0 | $3.78M | $3.00M | 0.68% | -$774.0K |
| Align Technology Inc | 16,000 | 15,000 | -1,000 | $2.50M | $2.57M | 0.58% | +$73.0K |
| Proqr Therapeutics N VSHS EURO SHS EURO | 1,567,561 | 1,567,561 | 0 | $3.17M | $2.54M | 0.58% | -$627.0K |
| Cybin D/B/A Helus Pharma(HELP) | 455,018 | 498,361 | +43,343 | $3.72M | $2.39M | 0.54% | -$1.33M |
| Rapport Therapeutics, Inc.(RAPP) | 75,000 | 75,000 | 0 | $2.28M | $2.35M | 0.53% | +$71.3K |
| Insulet Corporation(PODD) | 6,870 | 10,870 | +4,000 | $1.95M | $2.28M | 0.52% | +$328.2K |
| Structure Therapeutics IncADS | 37,000 | 46,500 | +9,500 | $2.57M | $2.24M | 0.51% | -$332.1K |
| Immatics N.V.SHS(IMTX) | 261,138 | 225,860 | -35,278 | $2.74M | $2.22M | 0.51% | -$519.5K |
| Celldex Therapeutics, Inc.(CLDX) | 68,518 | 68,518 | 0 | $1.86M | $2.17M | 0.49% | +$312.4K |
| Lexeo Therapeutics, Inc.(LXEO) | 340,859 | 377,059 | +36,200 | $3.38M | $2.16M | 0.49% | -$1.22M |
| Alector Inc | 908,351 | 908,351 | 0 | $1.42M | $1.95M | 0.44% | +$535.9K |
| Viking Therapeutics, Inc.(VKTX) | 59,516 | 59,516 | 0 | $2.09M | $1.94M | 0.44% | -$157.1K |
| Kura Oncology, Inc.(KURA) | 235,868 | 235,868 | 0 | $2.45M | $1.92M | 0.44% | -$533.1K |
| Profound Medical Corp.(PROF) | 285,710 | 263,005 | -22,705 | $2.25M | $1.70M | 0.39% | -$544.3K |
| Fulcrum Therapeutics, Inc.(FULC) | 0 | 205,000 | +205,000 | $0 | $1.57M | 0.36% | +$1.57M |
| Aquestive Therapeutics Inc | 375,915 | 368,415 | -7,500 | $2.43M | $1.53M | 0.35% | -$899.5K |
| MediWound Ltd.SHS NEW(MDWD) | 113,612 | 94,405 | -19,207 | $2.10M | $1.52M | 0.35% | -$576.4K |
| OrthoPediatrics Corp.(KIDS) | 0 | 95,659 | +95,659 | $0 | $1.52M | 0.35% | +$1.52M |
| Ultragenyx Pharmaceutical Inc.(RARE) | 16,000 | 61,100 | +45,100 | $368.0K | $1.28M | 0.29% | +$912.0K |
| Engene Holdings Inc COM | 163,645 | 187,353 | +23,708 | $1.48M | $1.28M | 0.29% | -$201.8K |
| Neurogene Inc.(NGNE) | 27,974 | 56,635 | +28,661 | $576.3K | $1.14M | 0.26% | +$565.5K |
| ARS Pharmaceuticals, Inc.(SPRY) | 190,065 | 139,285 | -50,780 | $2.21M | $1.12M | 0.25% | -$1.10M |
| CytomX Therapeutics, Inc.(CTMX) | 0 | 230,000 | +230,000 | $0 | $1.08M | 0.25% | +$1.08M |
| Maze Therapeutics, Inc.(MAZE) | 0 | 35,000 | +35,000 | $0 | $1.04M | 0.24% | +$1.04M |
| Mineralys Therapeutics, Inc.(MLYS) | 38,490 | 38,490 | 0 | $1.40M | $1.04M | 0.24% | -$354.1K |
| SCYNEXIS, Inc.(SCYX) | 0 | 1,086,956 | +1,086,956 | $0 | $996.6K | 0.23% | +$996.6K |
| ORIC Pharmaceuticals, Inc.(ORIC) | 141,045 | 98,724 | -42,321 | $1.15M | $945.5K | 0.22% | -$208.3K |
| Inspire Medical Systems, Inc.(INSP) | 8,600 | 18,200 | +9,600 | $793.2K | $938.8K | 0.21% | +$145.6K |
| PolyPid Ltd.(PYPD) | 207,900 | 207,900 | 0 | $902.3K | $910.6K | 0.21% | +$8.3K |
| TELA Bio, Inc.(TELA) | 1,441,029 | 1,441,029 | 0 | $1.70M | $893.4K | 0.20% | -$807.0K |
| Zenas BioPharma, Inc.(ZBIO) | 0 | 42,500 | +42,500 | $0 | $830.9K | 0.19% | +$830.9K |
| Verrica Pharmaceuticals Inc.(VRCA) | 173,451 | 153,712 | -19,739 | $1.44M | $813.1K | 0.18% | -$628.2K |
| Fate Therapeutics, Inc.(FATE) | 550,000 | 550,000 | 0 | $540.4K | $660.0K | 0.15% | +$119.6K |
| Annexon, Inc.(ANNX) | 272,812 | 117,812 | -155,000 | $1.37M | $652.7K | 0.15% | -$716.8K |
| Accuray Inc | 1,395,508 | 1,680,508 | +285,000 | $1.15M | $652.2K | 0.15% | -$498.5K |
| Newamsterdam Pharma Co ORDINARY SHARES | 0 | 20,000 | +20,000 | $0 | $640.2K | 0.15% | +$640.2K |
| Adicet Bio Inc | 93,812 | 93,812 | 0 | $789.9K | $638.9K | 0.15% | -$151.0K |
| BioNTech SEADS(BNTX) | 7,000 | 7,000 | 0 | $666.4K | $622.2K | 0.14% | -$44.2K |
| Pliant Therapeutics, Inc.(PLRX) | 0 | 487,000 | +487,000 | $0 | $613.6K | 0.14% | +$613.6K |
| Compugen Ltd.(CGEN) | 272,402 | 257,783 | -14,619 | $416.8K | $549.1K | 0.12% | +$132.3K |
| Orchestra BioMed Holdings, Inc.(OBIO) | 126,841 | 126,841 | 0 | $526.4K | $539.1K | 0.12% | +$12.7K |
| Foghorn Therapeutics Inc.(FHTX) | 126,859 | 111,859 | -15,000 | $685.0K | $534.7K | 0.12% | -$150.4K |
| iBio, Inc.(IBIO) | 0 | 193,638 | +193,638 | $0 | $367.9K | 0.08% | +$367.9K |
| Bicycle Therapeutics PlcADS | 64,492 | 64,492 | 0 | $456.6K | $299.2K | 0.07% | -$157.4K |
| ADC Therapeutics SASHS(ADCT) | 77,081 | 72,081 | -5,000 | $272.1K | $270.3K | 0.06% | -$1.8K |
| Karyopharm Therapeutics Inc.(KPTI) | 51,000 | 45,800 | -5,200 | $375.4K | $255.1K | 0.06% | -$120.3K |
| Autolus Therapeutics plcADS(AUTL) | 179,316 | 179,316 | 0 | $356.8K | $247.5K | 0.06% | -$109.4K |
| Neumora Therapeutics, Inc.(NMRA) | 0 | 70,000 | +70,000 | $0 | $136.5K | 0.03% | +$136.5K |
| Astria Therapeutics Inc | 304,775 | 0 | -304,775 | $3.99M | $0 | — | -$3.99M |
| BrainsWay Ltd.ADS(BWAY) | 12,965 | 0 | -12,965 | $246.6K | $0 | — | -$246.6K |
| Erasca, Inc.(ERAS) | 254,436 | 0 | -254,436 | $946.5K | $0 | — | -$946.5K |
| Perspective Therapeutics, Inc.(CATX) | 50,000 | 0 | -50,000 | $137.5K | $0 | — | -$137.5K |